1887

n African Journal of Science, Technology, Innovation and Development - Research and innovation for drug development in neglected diseases : a case study of India : research notes / commentaries

Volume 3, Issue 3
  • ISSN : 2042-1338
  • E-ISSN: 2042-1346
This article is unavailable for purchase outside of Africa

 

Abstract

This study investigated the research and innovation in 'neglected diseases' in India and the various modalities being undertaken to develop 'novel' drugs for these diseases. In spite of increase in scientific research and patent filing, examination of Indian pharmaceutical firm's activities shows that only a few firms are involved in the domain of neglected disease. Government is trying to bridge the 'translational gap' by stimulating public-private research partnership; however, private firms primarily exhibit profit motive for coming into public partnership. This model, as the evidences show, is not suitable for drug development in neglected diseases. The study explores other models that can broadly be placed under open innovation and argues that they are more promising for drug development in neglected diseases. It calls for more attention to these approaches as they provide incentives for actors to participate and moves away from the 'market centric' focus on drug development by firms leading to research only for lifestyle diseases effecting the north.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/aa_ajstid/3/3/EJC10597
2011-01-01
2019-08-21

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error